Y-mAbs Therapeutics (YMAB) PT Lowered to $11 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts YMAB Hot Sheet
Price: $8.61 --0%
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Robert Burns lowered the price target on Y-mAbs Therapeutics (NASDAQ: YMAB) to $11.00 (from $19.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Sarana Menara Nusantara Tbk (TOWR:IJ) (SMNUF) PT Lowered to IDR640 at Macquarie
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
